Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Fengqiong Hu
Institution:
The Affiliated Yongchuan Hospital of Chongqing Medical University
Observed institution:
The Affiliated Yongchuan Hospital of Chongqing Medical University
ORCID:
0009-0008-8488-0100
Observed ORCID:
0009-0008-8488-0100
OpenAlex ID:
A5016827742
CITED1 contributes to the progression of papillary thyroid carcinoma via the Wnt/β-catenin signaling pathway
2019
·
Ying Wang
, Huan Huang
, et al.
·
OncoTargets and Therapy
·
22
PDF
Extensive peritoneal implant metastases of malignant struma ovarii treated by thyroidectomy and 131I therapy: A case report
2018
·
Mengxue Wu
, Fengqiong Hu
, et al.
·
Medicine
·
19
Proteomic analysis of radioiodine‑refractory differentiated thyroid cancer identifies CHI3L1 upregulation in association with dysfunction of the sodium‑iodine symporter
2022
·
Yunjie Li
, Fengqiong Hu
, et al.
·
Oncology Letters
·
3
PDF
Investigation on low-iodine diet implementation by medical staff before radioactive iodine treatment for differentiated thyroid carcinoma
2024
·
Yupin Yi
, Yuquan Zhu
, et al.
·
Annals of Nuclear Medicine
·
2
PDF
Association of temporal and masseter muscle thickness with cognitive function and clinical severity in Alzheimer’s disease: a retrospective study
2026
·
Jing Li
, Xingqi Xiang
, et al.
·
Frontiers in Neuroscience
PDF
CHI3L1 Inhibits Expression of NIS by Activating MEK/ERK1/2 Signal Pathway in Thyroid Cancer
2021
·
Yunjie Li
, Fengqiong Hu
, et al.
·
Research Square
PDF
The ward’s management and control for 131 I treatment of differentiated thyroid cancer during novel coronavirus infection and epidemic period
2020
·
Yi Yupin
, Fengqiong Hu
·
Modern Medicine Health
Show more works
View as search
Works count:
7
Citation count:
46
H-index:
3
I10-index:
2
Year
Topic
Type